FDA Inspection 793984 — ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH
The FDA completed an inspection of ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH on July 26, 2012 in Radeberg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 26, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Radeberg (Germany)